Steward Partners Investment Advisory, LLC Bio Line Rx Ltd. Transaction History

Steward Partners Investment Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.63 - $4.88 $523 - $971	-199 Reduced 16.6%	1,000 $3,000
Q1 2021 May 14, 2021	BUY	$2.38 - $4.0 $157 - $264	66 Added 5.83%	1,199 $3,000
Q4 2020 Feb 11, 2021	BUY	$1.47 - $3.62 $1,665 - $4,101	1,133 New	1,133 $3,000

3.35M

46.5K

6.3K

Ticker BLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,524,500
Market Cap $12.3M
Description
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.